| S-(2-BORONOETHYL)-L-CYSTEINE HYDROCHLORIDE |
BEC HCL, 一个竞争性的 ARGINASE II抑制剂 |
222638-67-7 |
| (R)-2,2',3,3'-TETRAHYDRO-1,1'-SPIROBI[INDENE]-7,7'-DIOL, >=95% |
(R)-螺环二酚 |
223259-62-9 |
| 1,1'-SPIROBIINDANE-7,7'-DIOL |
消旋螺环二酚(RAC-1) |
223259-63-0 |
| AMINOPURVALANOL A |
AMINOPURVALANOL A |
220792-57-4 |
| 2-FLUORO-5-FORMYLBENZONITRILE |
2-氟-5-甲酰基苯腈 |
218301-22-5 |
| 6-BENZYL-2-CHLORO-5,6,7,8-TETRAHYDRO-1,6-NAPHTHYRIDINE |
6-苄基-2-氯-5,6,7,8-四氢-[1,6]萘啶 |
210539-04-1 |
| L-PYROGLUTAMIC ACID BETA-NAPHTHYLAMIDE |
L-焦谷氨酸-2-萘氨 |
22155-91-5 |
| GSK2982772 |
GSK2982772 |
1622848-92-3 |
| 9-Bromo-3-(2-Bromo Acetyl)-10,11-Dihydro-5H-dibenzo(c,g) Chromen-8(9H)-one |
9-溴-3-(2-溴乙酰基)-10,11-二氢-5H-二苯并(C,G) CHROMEN-8(9H)-酮 |
1438383-89-1 |
| N-((4-(4-phenylpiperazin-1-yl)tetrahydro-2H-pyran-4-yl)methyl)-2-(phenylthio)nicotinamide |
N-[[4-(4-PHENYLPIPERAZIN-1-YL)OXAN-4-YL]METHYL]-2-PHENYLSULFANYLPYRIDINE-3-CARBOXAMIDE |
1428327-31-4 |
| Methyl 3-broMo-4-fluoro-5-nitrobenzoate |
3-溴-4-氟-5-硝基苯甲酸甲酯 |
1403483-79-3 |
| methyl 3-amino-2-bromo-5-fluorobenzoate |
3-氨基-2-溴-5-氟苯甲酸甲酯 |
1342063-52-8 |
| Upadacitinib |
乌帕替尼 |
1310726-60-3 |
| tert-butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate |
艾乐替尼中间体 |
1256584-75-4 |
| 3-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline |
3-甲氧基-4-(4-(4-甲基哌嗪-1-基)哌啶-1-基)苯胺 |
1254058-34-8 |
| EAI-045 |
EAI-045 |
1942114-09-1 |
| 3-Bromo-5-chloropyridin-4-ol |
3-氯-5-溴-4-羟基吡啶 |
1822685-57-3 |
| 2-[(1H-pyrrolo[2,3-B]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl ring Hex-1-enyl]methyl]piperazin-1-yl]benzoic acid |
2-[(1H-吡咯并[2,3-B]吡啶-5-基)氧基]-4-[4-[[2-(4-氯苯基)-4,4-二甲基环己-1-烯基]甲基]哌嗪-1-基]苯甲酸 |
1235865-77-6 |
| Piperazine, 1-[(6-broMo-3-pyridinyl)Methyl]-4-ethyl- |
1-[(6-溴-3-吡啶基)甲基]-4-乙基-哌嗪 |
1231930-25-8 |
| 1H-BenziMidazole, 6-(2-chloro-5-fluoro-4-pyriMidinyl)-4-fluoro-2-Methyl-1-(1-Methylethyl)- |
6-(2-氯-5-氟-嘧啶-4-基)-4-氟-1-异丙基-2-甲基-1H-苯并咪唑 |
1231930-42-9 |
